Table 2 Seroprevalences of anti-infectious antibodies. % (95% CI).
From: Seroprevalences of autoantibodies and anti-infectious antibodies among Ghana’s healthy population
Variable | Greater Accra | Upper West | Eastern | Volta | Total |
|---|---|---|---|---|---|
Herpes simplex | |||||
HSV1 IgG | 98.8 (93.2–100) | 91.4 (82.3–96.8) | 97.4 (91–99.7) | 97.8 (93.6–99.5) | 96.7 (94.3–98.3) |
HSV2 IgG | 40 (29.2–51.6) | 15.7 (8.1–26.4) | 62.8 (51.1–73.5) | 21.5 (14.9–29.4) | 33.3 (28.5–38.4) |
Epstein-Bar virus | |||||
EBV-EA IgG | 11.3 (5.3–20.3) | 7 (2.3–15.7) | 6.4 (2.1–14.3) | 6.3 (3.1–11.3) | 7.5 (5.1–10.6) |
EBV-VCA IgM | 5 (1.4–12.3) | 20 (11.4–31.3) | 12.1 (4.5–19.2) | 20 (13.6–27.8) | 13 (9.7–16.8) |
EBV-VCA IgG | 100 (95.5–100) | 98.6 (92.4–99.7) | 97.4 (91–99.7) | 100 (97.7–100) | 99.2 (97.8–99.8) |
EBNA IgG | 90 (81.2–95.6) | 93 (84.3–97.7) | 80.8 (70.3–88.8) | 93.1 (88–96.5) | 90 (86.5–92.6) |
EBV-H IgM | 0 (0–4.5) | 0 (0–5.1) | 0 (0–4.6) | 0 (0–4) | 0.3 (0–1.5) |
